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ABSTRACT: The effect of 5% and 10% dietary incorporation of leaves of Vernonia amygdalina (VA) on oral glucose 
tolerance was studied in normoglycemic male albino rats. The feeding of the vegetable incorporated diets (5% VA 
and 10%VA) resulted in marked improvement in oral glucose tolerance in rats. After one week of diet administration, 
following an oral glucose load (3g/kg body weight), blood glucose concentration (BGC) (mg/dL) in rats fed the 5% 
VA peaked at 15minutes (147.24± 18.46), while the BGC in rats fed the control diet and 10% VA peaked at 30mins 
(180.00 ± 28.57 and 159.48 ± 16.07 respectively). After two weeks of feeding of the vegetable incorporated diets, post 
administration BGC peaked at 15 minutes in the test groups [5% VA diet (152.64± 33.46) and 10% VA diet group 
(121.95± 24.78)] while the peak remained at 30 minutes in the control group. After 3 weeks of diet administration 
BGC remained peaked at 15 minutes in the 5% and 10% VA diet groups (137.16 ± 61.29 and 132.75 ± 8.86 
respectively). Rats in both test groups, after 3 weeks on the test diets, had their glycaemic indices reduced by 15-
18%. These findings indicate that feeding on diets containing Vernonia amygdalina could positively modulate oral 
glucose tolerance. The vegetable could be useful in dietary management of conditions associated with oral glucose 
tolerance, and by extension, hyperglycemia. 
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INTRODUCTION 
The oral glucose tolerance test (OGTT) measures an 
individual organismʼs ability to utilize ingested glucose, the 
bodyʼs main source of energy, over a given period of time. 
OGTT is a good marker of the diabetic state and a test of 
immense value and when used in combination with fasting 
plasma glucose concentration, it facilitates the diagnosis of 
diabetes, as against using the latter alone. In fact, for a long 
time, it was the mainstay for the diagnosis of diabetes (Bartoli 
et al., 2011). 
Under normal physiological conditions, high blood glucose 
concentration promotes insulin release from the β-cells of the 
islets of Langerhans of the pancreas. Insulin stimulates the 
uptake of glucose by peripheral tissues especially skeletal 
muscle [by up-regulating the expression of glucose 
transporter-4 (GLUT-4) and by stimulating the exocytosis of 
stored GLUT-4], and promotes the storage of glucose in the 
liver (as glycogen) through the stimulation of glycogen 
synthase activity (Zunino, 2009; Zaid et al., 2008). Loss of 
responsiveness to insulin by insulin-responsive tissues 
results in the sustained elevation of blood glucose 
concentration (hyperglycemia), and ultimately to type 2 
diabetes mellitus, a metabolic condition that affects the 
metabolism of carbohydrates, lipids and proteins (Pareek et 
al., 2009). Besides hyperglycemia, type 2 diabetes mellitus is 
characterized by insulin resistance in peripheral tissues, and 
the eventual destruction of the β-cells of the islets of 
Langerhans (Guillausseau et al., 2008). It affects 285 million 
people (6.4%) globally, and is estimated to affect 438 million 
people by the year 2030, most of who would reside in 
developing countries (IDF, 2010). In fact, currently, diabetes 
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mellitus is thought to be the most prevalent endocrine 
disorder in Nigeria (Eseyin et al., 2010). 
A significant percentage of the population in sub-Saharan 
Africa and many countries in the developing and under-
developed regions of the world live in rural communities and 
have limited access to conventional medical treatment. 
Conventionally the management of diabetes mellitus involves 
non-pharmacological (diet control and exercise) and 
pharmacological (administration of insulin and hypoglycaemic 
drugs) approaches. Administration of exogenous insulin and 
oral hypoglycaemic agents such as biguanides and 
sulfonyureas) are the available orthodox therapies for the 
management of diabetes. These agents however do not 
revert the course of diabetic complications and often come 
with some toxicity (Pareek et al., 2009). The recommendation 
of the WHO supporting the search for plants that are effective 
in managing diabetes mellitus (WHO, 1980) and the thinking 
that botanicals are largely free from the toxicity associated 
with orthodox pharmaceuticals have emboldened the search 
for phytotherapeutics with anti-diabetic potentials. One plant 
that has been variously studied for usefulness in managing a 
wide array of medical conditions is Vernonia amygdalina Del.  
Vernonia amygdalina Del (Asteraceae) is a perennial shrub 
that grows to 2-5 m in height, throughout tropical Africa, and 
is commonly called bitter leaf. Its leaves are used traditionally 
in the preparation of soups and porridges. The plant 
reportedly finds application in the management of a myriad of 
ailments (Ijeh and Ejike, 2011). The hypoglycemic potentials 
of V. amygdalina had been reported as early as two decades 
ago (Akah and Okafor, 1992; Ogbuokiri and Ekpechi, 1989). 
Other researchers have used different preparations/extracts 
of the plant leaves, and have reported significant blood 
glucose lowering properties of the plant (Ijeh and Ejike, 
2011). In this report, we describe our investigation of the 
response of rats, fed a V. amygdalina incorporated diet, to an 
oral glucose challenge. 
MATERIALS AND METHODS 
Processing of plant materials and composition of test diets 
Fresh leaves of Vernonia amygdalina. Del were harvested 
from a local farm in Owerri, Imo State, Nigeria and were 
botanically identified by Dr GGE Osuagwu of the Department 
of Plant Science and Biotechnology, Michael Okpara 
University of Agriculture, Umudike, Abia State, Nigeria. The 
leaves were sorted to remove dead and wilted leaves and 
rinsed in clean tap water to remove dust and dirt. They were 
then air-dried at room temperature under a flowing fan until a 
constant dry weight was obtained. The leaves were milled to 
coarse fine powder, using a steel laboratory mill.  
The test diet was compounded by mixing milled standard 
growers feed (Vital Feeds Nigeria Limited) with the dried 
milled Vernonia amygdalina leaves in ratios of 95:5 and 
90:10 (feed/vegetable) to constitute the 5% VA and 10% VA 
diets respectively. The unmixed growers feed (100%) served 
as the control diet. The diets were then converted to pellets 
by extrusion through an improvised device made by neatly 
slicing the end of a 5 ml syringe. 
Rats 
Twenty four adult male Wistar rats (weight range 118−142 g) 
were obtained from the Animal Breeding Unit of the Faculty 
of Veterinary Medicine, University of Nigeria, Nsukka. On 
arrival, the rats were acclimatized to the animal house for one 
week before being randomly (while controlling for weight) 
assigned to six plastic cages (2 cages for each group of eight 
rats). The rats were exposed to approximately 12 hour 
light/dark cycles under humid tropical conditions, and given 
tap water and feed ad libitum throughout the duration of the 
study. 
Oral glucose tolerance test 
Oral glucose tolerance test was carried out using a 
modification of the method described by Taiwo et al. (2009). 
Rats were fasted overnight and given an oral glucose load of 
3 g/kg body weight per os. Following the oral glucose load, 
blood was obtained at 0, 15, 30, 45 and 60 minutes from the 
tail vein of the rat and analysed for glucose using a 
glucometer (Accu-check Advantage, Roche Diagnostics, 
Mannheim). The procedure was repeated after one, two and 
three weeks of feeding the test rats on the test diets. From 
the data generated from the OGTT, the positive incremental 
area under the curve (AUC) was calculated for each group 
using the equation: 
AUC = {[(t1-t0)÷2] × (C0+C1)} + {[(t2-t1)÷2] × (C1+C2)} + {[(t3-
t2)÷2] × (C3+C2)}… 
(where t = time and C = concentration of glucose) (Brouns et 
al., 2005). 
The glycaemic index was calculated as:  
GI = AUCtest/AUCcontrol 
Statistical analysis 
The data generated were subjected to descriptive statistical 
analysis, and a comparison of differences between means 
using One Way ANOVA. A significant threshold of P <0.05 
was employed for the analysis. Data analysis was carried out 
using SPSS version 18.0 (SPSS Inc, Chicago, IL). The 
results are presented as line graphs generated using 
Microsoft Excel (Microsoft Corp., Redmond, WA). 
RESULTS AND DISCUSSION 
The oral glucose tolerance test is a good and cheap measure 
of insulin secretion, sensitivity and glucose uptake (Rhee et 
al., 2010; Matsuda and DeFronzo, 1999) and since an 
impaired glucose tolerance is an indication of a deranged 
glucose metabolism and a pointer to subsequent diabetes 
Ijeh et al. Glucose tolerance in rats fed Vernonia amygdalina leaves Biokemistri 25(1): 1–5 
 3	  
(Eseyin et al., 2010), the test is good for studying agents that 
improve glucose tolerance and, by extension, are useful in 
the management of diabetes (and diabetic complications). Its 
main advantage is in its ability to detect stages of pre-
diabetes more accurately than other methods, and its ability 
to investigate postprandial glucose levels in a physiological 
way (Luijf et al., 2011). 
 
	  
Figure 1: OGTT after one week of feeding on the 5 and 
10% Vernonia amygdalina incorporated diets. 
The results (Figures 1-3) revealed that after the first week of 
feeding on the test diets blood glucose concentration (BGC) 
peaked at 15 minutes in the group fed 5% VA incorporated 
diet while the group fed the control diet and the 10% VA diet 
had peak BGC at 30 minutes, following an oral glucose load. 
Blood glucose concentration however peaked at 15 minutes 
in the 5% VA diet and 10% VA diet groups after 3 weeks of 
feeding on the vegetable diet but the BGC peak remained at 
30 minutes in the control group throughout the study. Also 
after two weeks of feeding on the test diet, BGC was 
significantly (P < 0.05) lower in the group fed 10% VA 
incorporated diet relative to the control group 30 minutes 
after the glucose load. After 3 weeks of feeding on the test 
diet there was a significant (P < 0.05) reduction in BGC at 30 
minutes in both test groups, relative to the control group. 
Peak BGC was lower in the test groups throughout the period 
of the study indicating that VA had hypoglycaemic properties. 
Furthermore, by the end of the third week, both test diets 
considerably lowered the AUCʼs for the OGTT curves, giving 
glycaemic indices that had shrunk by more than 15% each 
(Table 1). 
These findings show that dietary incorporation of Vernonia 
amygdalina improved oral glucose tolerance as indicated by 
the lower glucose concentrations at peak BGC in the test 
groups, the reduction in the time it took to reach the peak 
BGC and for the decline to begin, and the reduction in the 
AUC for the OGTT curves and the glycaemic indices of the 
test diets. There are two mechanisms that could explain the 
glycaemic effects observed here. The active principles in the 
test diets could (1) slow down glucose transport into the 
blood from the lumen of the gastro-intestinal tract, or (2) 
improve insulin secretion and/or sensitivity, and thus glucose 
transport from the blood to the other tissues, and its 
utilization there. Though these are speculations (as further 
studies are required to establish the exact mechanism(s) of 
action of the agents), it is obvious that agents that affect 
glucose metabolism employ the mentioned mechanisms. 
While the first mechanism ensures that glucose does not get 
over-loaded in the blood, the second ensures that the 
glucose is utilized rapidly by the cell (Kalsbeek et al., 2010). 
The finding of lower glycaemic indices in the test groups at 
the end of the study supports the former mechanism, but 
does not preclude the latter.  
 
	  
Figure 2: OGTT after two weeks of feeding on the 5 and 
10% Vernonia amygdalina incorporated diets. 
	  
	  
Figure 3: OGTT after three weeks of feeding on the 5 and 
10% Vernonia amygdalina incorporated diets. 
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These findings also show that the improvement in blood 
glucose tolerance was time dependent as seen in Figure 3 
which shows that there was a decrease in peak blood 
glucose concentration after three weeks of feeding when 
compared with the peak observed after the first and second 
weeks of feeding the vegetable diet. This implies that the 
consumption of the test diet had a cumulative advantage. 
The improvement of glucose tolerance with time suggests 
that when consumed habitually, the test diet could be useful  
in the prevention of diabetes; and for those already diabetic, 
it may be useful in regulating glucose utilization after a 
carbohydrate-rich meal. This is particularly useful, as the bulk 
of the challenge of diabetics is keeping the blood glucose 
levels within the physiological threshold. Pharmacologic 
agents used to achieve such regulation often result in 
hypoglycemia which could be very dangerous (Brod et al., 
2011). Going by the data presented here, the consumption of 
VA as parts of the regular diet could be useful for diabetics as 
it could help regulate their blood glucose levels, thereby 
preventing hyperglycemia and in turn reduce their 
dependence on pharmacologic agents. 
Several reports indicate that the extracts of VA have 
hypoglycaemic potentials (Ijeh and Ejike, 2011). However, 
little has been investigated about the use of diets 
incorporated with the plant leaves in the management of 
diabetes and related metabolic disorders. Because 
adherence to drug/dietary regimens by diabetic subjects is 
often poor (Davies et al., 2013; Mann et al., 2009), the use of 
VA in diets may be very useful especially in the South                       
Eastern parts of Nigeria where the plant leaves are used in 
the preparation of a variety of soups. This allows subjects 
take the preparations without the psychological feeling that 
they are taking medications, a factor that helps in ensuring 
compliance. Such use would maximize the utilization of all 
the pharmacologic principles in the plant leaves that might be 
important for the observed biochemical effects. 
This study may be limited by its scope, as it did not 
investigate the mechanism of improvement in oral glucose 
tolerance, and the effects of the diet on metabolic parameters 
downstream of impaired glucose metabolism. Those are 
subjects of our on-going research. However, this is to our 
knowledge the first report of the usefulness of diets 
incorporated with the leaves of VA in the improvement of oral 
glucose tolerance. The inherent advantages of this approach 
are at the core of the strength of this study. 
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